Skip to main content

Volume 12 - Issue 7 - July, 2015

Feature

Case Report
07/01/2015
Robert Coronado, MD
Venous insufficiency is the most common vascular disorder today, and it is underdiagnosed and misdiagnosed. This commentary aims to enhance understanding of venous insufficiency and the current treatments available.
Venous insufficiency is the most common vascular disorder today, and it is underdiagnosed and misdiagnosed. This commentary aims to enhance understanding of venous insufficiency and the current treatments available.
Venous insufficiency is the most...
07/01/2015
Vascular Disease Management
Original Research
07/01/2015
Seung-Woon Rha, MD, PhD; Michael S. Lee, MD, DPM, FACFAS, FACC, FSCAI; Cheol Ung Choi, MD; Jin Oh Na, MD; Hong Euy Lim, MD; Jin Won Kim, MD; Seung-Kyu Han, MD; Eung-Ju Kim, MD; Byoung Geol Choi, MS, BS; Chang Gyu Park, MD; Se Yeon Choi, MS, BS; Hong Seog Seo, MD; Ji Bak Kim, MD; Dong Joo Oh, MD; Sunki Lee, MD; Jabar Ali, MD; Shaopeng Xu, MD; Harris Abdullah Ngow, MD; Jae Joong Lee, MD; Pejman Mansourian, MD; Gwang No Lee, MD
The authors compare clinical outcomes of male and female patients with PAD who underwent percutaneous transluminal angioplasty. 
The authors compare clinical outcomes of male and female patients with PAD who underwent percutaneous transluminal angioplasty. 
The authors compare clinical...
07/01/2015
Vascular Disease Management

Column

Clinical Editor's Corner
07/01/2015
Treatment of in-stent restenosis with standard balloon angioplasty has been associated with poor patency and complications. New therapy options that add lasers and drug-eluting technologies could improve results.
Treatment of in-stent restenosis with standard balloon angioplasty has been associated with poor patency and complications. New therapy options that add lasers and drug-eluting technologies could improve results.
Treatment of in-stent restenosis...
07/01/2015
Vascular Disease Management

Insights

Interview
07/01/2015
Jennifer Ford
At the 2015 New Cardiovascular Horizons meeting, Vascular Disease Management spoke with VISION trial investigator Patrick Muck, MD, and Avinger founder and CEO John B. Simpson, MD, about the VISION trial and the Pantheris system.
At the 2015 New Cardiovascular Horizons meeting, Vascular Disease Management spoke with VISION trial investigator Patrick Muck, MD, and Avinger founder and CEO John B. Simpson, MD, about the VISION trial and the Pantheris system.
At the 2015 New Cardiovascular...
07/01/2015
Vascular Disease Management
Interview
07/01/2015
Dr. Walker, an interventional cardiologist with Cardiovascular Institute of the South and a clinical professor of medicine at Tulane University and LSU medical schools, served as an EXCITE ISR co-principal investigator. Vascular Disease...
Dr. Walker, an interventional cardiologist with Cardiovascular Institute of the South and a clinical professor of medicine at Tulane University and LSU medical schools, served as an EXCITE ISR co-principal investigator. Vascular Disease...
Dr. Walker, an interventional...
07/01/2015
Vascular Disease Management